DOCSLIB.ORG

The Nature and Applications of Tryptic Enzymes in Veterinary Practice

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Nature and Applications of Tryptic Enzymes in Veterinary Practice Volume 20 | Issue 1 Article 1 1958 The aN ture and Applications of Tryptic Enzymes in Veterinary Practice Earl F. Huffman Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian Part of the Veterinary Toxicology and Pharmacology Commons Recommended Citation Huffman, Earl F. (1958) "The aN ture and Applications of Tryptic Enzymes in Veterinary Practice," Iowa State University Veterinarian: Vol. 20 : Iss. 1 , Article 1. Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol20/iss1/1 This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact [email protected]. The Nature And Applications Of TRYPTIC ENZYMES IN VETERINARY PRACTICE Earl F. Huffman, D.V.M. NZYMES, or ferments as they were glands of domestic animals (trypsin), or E known in earlier times, have been from the vegetable kingdom as in the case used in medicine for centuries. From the of papain. time of Pasteur interest in enzymes has Of the three major types papain is per­ increased till, at the present date, we have haps the most proteolytic of the group (1). active research groups devoting much However, it strongly attacks viable mam­ time and money to the study of the nature malian proteins and is difficult to control and applied uses of a great variety of unless very closely supervised in its ap­ enzymes. plication. For that reason papain has be­ . Most chemical reactions which occur in come restricted in routine use in medicine, living cells are accelerated by enzymes. The mammalian enzymes such as tryp­ Essentially, enzymes are biological cata­ sin and chymotrypsin have been intensely lysts and are protein in nature. Most en­ tested as debriding agents in wound treat­ zymes are water soluble. As they exist ments and found to be safe for routine use within the mammalian body, enzymes may (2, 3, 4, 5). One of the first crude uses of be surrounded by other proteins. They are trypsin was in the application of maggots thus completely liberated only when this to gangrenous wounds during World War protein is dissolved since they cannot dif­ 1. It has since been found that the blow fuse through it. Enzymes are amphoteric fly maggots elaborated a tryptic substance in character and, as such, act as electro­ which accomplished an efficient digestion lytes in various solutions (1). of necrotic material in wounds, especially Proteolytic enzymes, at the present time, infected type injuries. command the greatest interest in the field Recent studies (2, 3, 6, 7) in the field of medicine and surgery. The common of medicine and veterinary medicine have sources of these products are from certain indicated their value in conditions which streptococci (streptokinase), the pancreas would require radical surgical procedures Dr. Huffman received his degree from Michi­ to effect debridement of dirty wounds be­ gan State University in 1952. He is Manager, fore healing could be accomplished. Tryp­ Professional Relations, Armour Veterinary Lab­ oratories. sin has been used very effectively in the Issue 1, 1958 9 treatment of topical injuries and has also been suc~essfully used in intrathoracic applications (2, 8) to resolve the empyema associated with tuberculosis. TRYPSIN .AND ,ITS ACTIONS Trypsin is available to the veterinary profession in a purified, lyophilized crys­ talline form (9). This for;m (Tryptar­ Vet®, Armour Veterinary Laboratories) is the activated trypsin and is ready to function, when applied directly to moist wounds or applied by irrigatidns or wet packs to q.ry necrotic type lesiqns. It has been demonstrated both expe~imentally (2) and clinically (3,8) that the I£ollowing sequence of events occur when trypsin is applied to wounds. The necrotic material can be seen ito be­ come loosened and dissolved from the sub­ strate of the wound. Trypsin does not digest normal healthy tissue. Pathological leucocytes rapidly disappear from the wound and normal leucocytes enter into the area. Healthy regenerating tissue forms rapidly to accelerate healing. There is no side reaction whatsoever Dr. Earl F. Huffman attendant with trypsin usage in open, freely-draining wounds. In treating car­ uncle conditions, as in fistulous withers of 6, 7) and most recently in experimental the llorse, adequate drainage must be es­ animals that severely infected wounds or tablished. Tryptic digestion of tissue may cleanly induced surgical wounds (12) liberate histamine substances (6, 8, 10) treated with trypsin heal more rapidly which could be absorbed and cause a than similar wounds in control animals.' transient pyrexia and occasional stinging. Surgical excision of the nerves controlling In these. instances antihistamine adminis­ the blink reflex of rabbits resulted in re­ tered at usual dosages for the species will generation of the nerves on an average of counteract this effect. Upon repeated use 5 days earlier with trypsin treated animals of trypsin this phenomenon does not ap­ as opposed to controls. W oundhealing pear again. which occurs at the skin surface heals on The digestive action of trypsin breaks an average of 2 days earlier than controls. down proteins and partially hydr;olyzed Puncture wounds on test animals heal proteins at peptide linkages (1, 11). This much more rapidly the first 3 days follow­ results in liquefaction of necrotic tissue ing injury in trypsin treated cases than do without formation of ~ntermediate pro­ untreated controls or controls treated with ducts which may cause anaphylactic reac­ hydrocortisone. tions. In the human and. the animal, tryp­ Trypsin injected parenterally (2, 13, 14, sin does not cause production of antibodies 15) re,sults in a pronounced anti-inflam­ or any undesirable side reactions when' matory response being elicited in a variety applied topically or in body cavities where of pathological conditions where inflam­ aspiration may be accomplished or free mation is always present. However, it has drainage established.- been found that intravenous use of trypsin It has been demonstrated clinically (3, interferes with the anti-clotting mechan- 10 Iowa State College Veterinarian isms in the blood stream and such action otics to cont:rol the infection. may result in formation of intravascular It has been found in human cases (8) clots (16,17). This phenomenon will occur that the introduction of 500,000 units into in laboratory animals even in the absence the thoracic cavity of chronic tubercular of calcium ions. In many case studies (2, cases with empyema results in a rapid li­ 3, 6, 7, 8) trypsin has resulted in the cir­ quefaction of the empyema making pos­ cumvention of radical surgery 'and has sible easy aspiration and drainage of the effected permanent healing of many . affected pleura. Also, after a few treat­ chronic conditions which were refractive ments the tubercular organisms can no to the accepted means of therapy. longer be detected in the affected area. This has been adequately demonstrated Similar effects upon bacteria (2, 3) are by Johnson, et al., in the following com­ noted in many other infected type wounds. mon conditions. For fistulous withers in Following a few applications of trypsin horses (cases in which drainage has been the invading bacteria carinot be detected. established naturally or where surgical This is assumed to be due to the effect of . incision was required) approximately trypsin upon altering the substrate of the 400,000 units (Armour units, 1,000 units area of injury so that pathogenic bacteria = 1 mg. tryptic activity) 'Of t:rypsin daily can no longer secure nutrition from the for 7 days has induced normal repair site and, hence, die away. It has also been prosesses. shown that trypsin digests the capsular A solution of the enzyme may be inject­ material from many pathogenic micro­ ed into the area- or irrigated through the organisms. This must not be construed to fistulous tracts.. 'J:'he crystalline material mean that trypsin is antibiotic, but this may be blowrtinto the lesions with a pow­ feature combined with such agents en­ der blower, or it may be inserted in fistu­ hances the effect of antibiotic therapy in lous tracts by use of gelatin capsules. many conditions. Foot rot in cattle as with foot canker in Chronically infected sinuses in cattle horses has been satisfactorily resolved and horses have been cured through in­ through daily use of trypsin. Two-hundred troduction of trypsin solution into the si­ thousand to 400,000 units applied directly nus and allowing it to remain for about to the lesion or injected into the fistula is 24 hours, then tilting the head or estab­ sufficient for a daily treatment. Continued lishing surgical drainage to drain out the for a week or less, this therapy results in liquefied material. This resulted under normal healing of the condition. This has conditions where antibiotics or methods of in several instances circumvented ampu­ flushing the sinus hadyield~d poor results. tation of the claw to correct foot rot. In t:reatmentt of topical \:wounds, ab­ Trypsin may be injected directly into scesses and hematomas, the, amount' of pus-filled joint capsules, allowed to work trypsin to use depends upon \ the extent~ for a few hours, then aspirated, leaving the and nature of the injury. On \he whole, joint free of caseous or purulent material. small lesions, a few inches in area, would In cases of gangrenous and purulent not require more than 50,000 tq 100,000 mastitis, depending upon the size of the units of trypsin daily until resolution of infected area, 200,000 to 800,000 units of the condition is evident. Most of these trypsin· daily results in considerable re­ resolve after one to three applications of duction- of inflammation.
Load more

Recommended publications
  • (12) Patent Application Publication (10) Pub. No.: US 2016/0346364 A1 BRUNS Et Al
    US 2016.0346364A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2016/0346364 A1 BRUNS et al. (43) Pub. Date: Dec. 1, 2016 (54) MEDICAMENT AND METHOD FOR (52) U.S. Cl. TREATING INNATE IMMUNE RESPONSE CPC ........... A61K 38/488 (2013.01); A61K 38/482 DISEASES (2013.01); C12Y 304/23019 (2013.01); C12Y 304/21026 (2013.01); C12Y 304/23018 (71) Applicant: DSM IPASSETS B.V., Heerlen (NL) (2013.01); A61K 9/0053 (2013.01); C12N 9/62 (2013.01); A23L 29/06 (2016.08); A2ID 8/042 (72) Inventors: Maaike Johanna BRUINS, Kaiseraugst (2013.01); A23L 5/25 (2016.08); A23V (CH); Luppo EDENS, Kaiseraugst 2002/00 (2013.01) (CH); Lenneke NAN, Kaiseraugst (CH) (57) ABSTRACT (21) Appl. No.: 15/101,630 This invention relates to a medicament or a dietary Supple (22) PCT Filed: Dec. 11, 2014 ment comprising the Aspergillus niger aspergilloglutamic peptidase that is capable of hydrolyzing plant food allergens, (86). PCT No.: PCT/EP2014/077355 and more particularly, alpha-amylase/trypsin inhibitors, thereby treating diseases due to an innate immune response S 371 (c)(1), in humans, and/or allowing to delay the onset of said (2) Date: Jun. 3, 2016 diseases. The present invention relates to the discovery that (30) Foreign Application Priority Data the Aspergillus niger aspergilloglutamic peptidase is capable of hydrolyzing alpha-amylase/trypsin inhibitors that are Dec. 11, 2013 (EP) .................................. 13196580.8 present in wheat and related cereals said inhibitors being strong inducers of innate immune response. Furthermore, Publication Classification the present invention relates to a method for hydrolyzing alpha-amylase/trypsin inhibitors comprising incubating a (51) Int.
    [Show full text]
  • Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases
    International Journal of Molecular Sciences Review Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases Emma L. Carroll 1,†, Mariarca Bailo 2,†, James A. Reihill 1 , Anne Crilly 2 , John C. Lockhart 2, Gary J. Litherland 2, Fionnuala T. Lundy 3 , Lorcan P. McGarvey 3, Mark A. Hollywood 4 and S. Lorraine Martin 1,* 1 School of Pharmacy, Queen’s University, Belfast BT9 7BL, UK; [email protected] (E.L.C.); [email protected] (J.A.R.) 2 Institute for Biomedical and Environmental Health Research, School of Health and Life Sciences, University of the West of Scotland, Paisley PA1 2BE, UK; [email protected] (M.B.); [email protected] (A.C.); [email protected] (J.C.L.); [email protected] (G.J.L.) 3 Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University, Belfast BT9 7BL, UK; [email protected] (F.T.L.); [email protected] (L.P.M.) 4 Smooth Muscle Research Centre, Dundalk Institute of Technology, A91 HRK2 Dundalk, Ireland; [email protected] * Correspondence: [email protected] † These authors contributed equally to this work. Abstract: Trypsin-like proteases (TLPs) belong to a family of serine enzymes with primary substrate specificities for the basic residues, lysine and arginine, in the P1 position. Whilst initially perceived as soluble enzymes that are extracellularly secreted, a number of novel TLPs that are anchored in the cell membrane have since been discovered. Muco-obstructive lung diseases (MucOLDs) are Citation: Carroll, E.L.; Bailo, M.; characterised by the accumulation of hyper-concentrated mucus in the small airways, leading to Reihill, J.A.; Crilly, A.; Lockhart, J.C.; Litherland, G.J.; Lundy, F.T.; persistent inflammation, infection and dysregulated protease activity.
    [Show full text]
  • Mixture of Trypsin, Chymotrypsin and Papain Reduces Formation of Metastases and Extends Survival Time of C57bl6 Mice with Syngeneic Melanoma B16
    Cancer Chemother Pharmacol #2001) 47 #Suppl): S16±S22 Ó Springer-Verlag 2001 ORIGINAL ARTICLE Martin Wald á Toma sÏ Oleja r á Veronika SÏ ebkova Marie Zadinova á Michal Boubelõ k á Pavla PoucÏ kova Mixture of trypsin, chymotrypsin and papain reduces formation of metastases and extends survival time of C57Bl6 mice with syngeneic melanoma B16 Abstract Purpose: The aim of the present study was to decreased expression of CD44 and CD54 molecules in investigate the eect of a mixture of proteolytic enzymes tumors exposed to proteolytic enzymes in vivo. #comprising trypsin, chymotrypsin and papain) on the Conclusions: Our data suggest that serine and cysteine metastatic model of syngeneic melanoma B16. Methods: proteinases suppress B16 melanoma, and restrict its 140 C57Bl6 mice were divided into two control and two metastatic dissemination in C57Bl6 mice. ``treated'' groups. Control groups received saline rectally, twice a day starting 24 h after intracutaneous Key words Trypsin á Papain á B16 melanoma á transplantation #C1) or from the time point of the Metastasis primary B16 melanoma extirpation #C2), respectively. ``Treated'' groups were rectally administered a mixture of 0.2 mg trypsin, 0.5 mg papain, and 0.2 mg chymo- Introduction trypsin twice daily starting 24 h after transplantation #E1) or after extirpation of the tumor #E2), respectively. Lack of requisite immune surveillance in tissue dier- Survival of mice and B16 melanoma generalization were entiation is an important mechanism that gives rise to a observed for a period of 100 days. Immunological clone of malignant cells, which eventuates in tumori- evaluation of B16 melanoma cells in the ascites was genesis.
    [Show full text]
  • TMPRSS2 and Furin Are Both Essential for Proteolytic Activation and Spread of SARS-Cov-2 in Human Airway Epithelial Cells and Pr
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.15.042085; this version posted April 15, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 TMPRSS2 and furin are both essential for proteolytic activation and spread of SARS- 2 CoV-2 in human airway epithelial cells and provide promising drug targets 3 4 5 Dorothea Bestle1#, Miriam Ruth Heindl1#, Hannah Limburg1#, Thuy Van Lam van2, Oliver 6 Pilgram2, Hong Moulton3, David A. Stein3, Kornelia Hardes2,4, Markus Eickmann1,5, Olga 7 Dolnik1,5, Cornelius Rohde1,5, Stephan Becker1,5, Hans-Dieter Klenk1, Wolfgang Garten1, 8 Torsten Steinmetzer2, and Eva Böttcher-Friebertshäuser1* 9 10 1) Institute of Virology, Philipps-University, Marburg, Germany 11 2) Institute of Pharmaceutical Chemistry, Philipps-University, Marburg, Germany 12 3) Department of Biomedical Sciences, Carlson College of Veterinary Medicine, Oregon 13 State University, Corvallis, USA 14 4) Fraunhofer Institute for Molecular Biology and Applied Ecology, Gießen, Germany 15 5) German Center for Infection Research (DZIF), Marburg-Gießen-Langen Site, Emerging 16 Infections Unit, Philipps-University, Marburg, Germany 17 18 #These authors contributed equally to this work. 19 20 *Corresponding author: Eva Böttcher-Friebertshäuser 21 Institute of Virology, Philipps-University Marburg 22 Hans-Meerwein-Straße 2, 35043 Marburg, Germany 23 Tel: 0049-6421-2866019 24 E-mail: [email protected] 25 26 Short title: TMPRSS2 and furin activate SARS-CoV-2 spike protein 27 28 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.15.042085; this version posted April 15, 2020.
    [Show full text]
  • Intrinsic Evolutionary Constraints on Protease Structure, Enzyme
    Intrinsic evolutionary constraints on protease PNAS PLUS structure, enzyme acylation, and the identity of the catalytic triad Andrew R. Buller and Craig A. Townsend1 Departments of Biophysics and Chemistry, The Johns Hopkins University, Baltimore MD 21218 Edited by David Baker, University of Washington, Seattle, WA, and approved January 11, 2013 (received for review December 6, 2012) The study of proteolysis lies at the heart of our understanding of enzyme evolution remain unanswered. Because evolution oper- biocatalysis, enzyme evolution, and drug development. To un- ates through random forces, rationalizing why a particular out- derstand the degree of natural variation in protease active sites, come occurs is a difficult challenge. For example, the hydroxyl we systematically evaluated simple active site features from all nucleophile of a Ser protease was swapped for the thiol of Cys at serine, cysteine and threonine proteases of independent lineage. least twice in evolutionary history (9). However, there is not This convergent evolutionary analysis revealed several interre- a single example of Thr naturally substituting for Ser in the lated and previously unrecognized relationships. The reactive protease catalytic triad, despite its greater chemical similarity rotamer of the nucleophile determines which neighboring amide (9). Instead, the Thr proteases generate their N-terminal nu- can be used in the local oxyanion hole. Each rotamer–oxyanion cleophile through a posttranslational modification: cis-autopro- hole combination limits the location of the moiety facilitating pro- teolysis (10, 11). These facts constitute clear evidence that there ton transfer and, combined together, fixes the stereochemistry of is a strong selective pressure against Thr in the catalytic triad that catalysis.
    [Show full text]
  • Faecal Elastase 1: Not Helpful in Diagnosing Chronic Pancreatitis Associated with Mild to Gut: First Published As 10.1136/Gut.42.4.551 on 1 April 1998
    Gut 1998;42:551–554 551 Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to Gut: first published as 10.1136/gut.42.4.551 on 1 April 1998. Downloaded from moderate exocrine pancreatic insuYciency P G Lankisch, I Schmidt, H König, D Lehnick, R Knollmann, M Löhr, S Liebe Abstract tion. The former is particularly helpful Background/Aim—The suggestion that only in detecting severe EPI, but not the estimation of faecal elastase 1 is a valuable mild to moderate form, which poses the new tubeless pancreatic function test was more frequent and diYcult clinical prob- evaluated by comparing it with faecal chy- lem and does not correlate significantly motrypsin estimation in patients catego- with the severe morphological changes rised according to grades of exocrine seen in chronic pancreatitis. pancreatic insuYciency (EPI) based on (Gut 1998;42:551–554) the gold standard tests, the secretin- pancreozymin test (SPT) and faecal fat Keywords: faecal elastase 1; faecal chymotrypsin; analysis. secretin-pancreozymin test; faecal fat analysis; exocrine pancreatic insuYciency; diagnosis Methods—In 64 patients in whom EPI was suspected, the following tests were per- formed: SPT, faecal fat analysis, faecal The diagnosis of chronic pancreatitis is usually chymotrypsin estimation, faecal elastase 1 based on abnormal results from pancreatic estimation. EPI was graded according to function tests and morphological examin- the results of the SPT and faecal fat ation.1 For the evaluation of exocrine pancre- analysis as absent, mild, moderate, or atic function, there are both direct and indirect severe. The upper limit of normal for fae- tests.
    [Show full text]
  • Role of Chicken Pancreatic Trypsin, Chymotrypsin and Elastase in the Excystation Process of Eimeria Tenella Oocysts and Sporocysts
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Obihiro University of Agriculture and Veterinary Medicine Academic Repository Role of Chicken Pancreatic Trypsin, Chymotrypsin and Elastase in the Excystation Process of Eimeria tenella Oocysts and Sporocysts 著者（英） Guyonnet Vincent, Johnson Joyce K., Long Peter L. journal or The journal of protozoology research publication title volume 1 page range 22-26 year 1991-10 URL http://id.nii.ac.jp/1588/00001722/ J. Protozool. Res., 1. 22-26(1991) Copyright © 1991 , Research Center for Protozoan Molecular Immunology Role of Chicken Pancreatic Trypsin, Chymotrypsin and Elastase in the Excystation Process of Eimeria tenella Oocysts and Sporocysts VINCENT GUYONNET, JOYCE K. JOHNSON, and PETER L. LONG Department of Poultry Science, The University of Georgia Athens, GA 30602, U.S.A. Recieved 2 September 1991 / Accepted October 5 1991 Key words: chymotrypsin, Eimeria tenella, elastase, excystation, trypsin ABSTRACT The role of pancreatic proteolytic enzymes in the excystation process of Eimeria tenella oocysts and sporocysts was studied in vitro. Intact sporulated oocysts were preincubated in phosphate buffer, NaCl 0.9% (PBS) added with 0.5% chicken bile extract in a 5% C02 atmosphere for 30 minutes prior to exposure to either 0.25% (w/v) chicken trypsin, chymotrypsin, pancreatic elastase, or a 1% (w/v) crude extract of unsporulated and sporulated oocysts of E. tenella (Expt.1). No excystation was observed under these conditions. Sporocysts were also incubated under the same conditions without pretreatment in C02. Excystation was observed for sporocysts incubated with either trypsin, chymotrypsin or pancreatic elastase, the best percentage of excystation being recorded for the latter after 5 hours (Expt.
    [Show full text]
  • 372 Trypsin-Chymotrypsin Alternation and Other
    372 TRYPSIN-CHYMOTRYPSIN ALTERNATION AND OTHER DIGESTIVE ENZYMES DURING THE DAILY DIGESTION IN EARLY SENEGAL SOLE JUVENILES N. Gilannejad 1, C. Navarro-Guillén 1, G. Martínez-Rodríguez 1, F.J. Moyano 2, M. Yúfera 1 1 Instituto de Ciencias Marinas de Andalucía (ICMAN-CSIC), 11519 Puerto Real, Cádiz, Spain. 2 Dept. Biology and Geology, University of Almería, 04120-Almería, Spain * E-mail: [email protected] Introduction The improvement of diets and the utilization of their nutrients by growing fish is a major challenge in fish farming. In vitro experiments with customized bioreactors simulating the digestion conditions are considered as an easy-working and quick methodology for improving feed formulation. Nevertheless, it is first necessary to define realistic digestion conditions according to the target species. In a first step to advance in the integral knowledge of the digestive function in Senegal sole (Solea senegalensis), we have analysed the activity pattern of some key digestive enzymes during a 24 hours period in early juveniles with different daily feeding frequencies. Materials and methods Juvenile Senegal sole with an average weight of 10±0.3 g were reared in four 400-L tanks with flow-through water system with a temperature of 19.5 ± 1.0 ° C and a natural light/dark photoperiod. Fish were fed daily on an experimental diet with a ratio of 2% fish wet weight with four different feeding protocol: a) one daily meal at 9:00 h (local time), b) six daily meals during daylight at 08:30, 10:00, 12:00, 14:00, 16:00, and 18:00 h, c) six daily meals during night at 20:00, 22:00, 24:00, 02:00, 04:00 and 06:00 and, d) 12 daily meals during 24 hour (at times mentioned in protocols b and c).
    [Show full text]
  • BMC Structural Biology Biomed Central
    BMC Structural Biology BioMed Central Research article Open Access A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases Alexander Wlodawer*1, Stewart R Durell2, Mi Li1,3, Hiroshi Oyama4, Kohei Oda4 and Ben M Dunn5 Address: 1Protein Structure Section, Macromolecular Crystallography Laboratory, National Cancer Institute at Frederick, Frederick, MD 21702, USA, 2Laboratory of Experimental and Computational Biology, National Cancer Institute, Bethesda, MD 20892, USA, 3Basic Research Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, MD 21702, USA, 4Department of Applied Biology, Faculty of Textile Science, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan and 5Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610, USA Email: Alexander Wlodawer* - [email protected]; Stewart R Durell - [email protected]; Mi Li - [email protected]; Hiroshi Oyama - [email protected]; Kohei Oda - [email protected]; Ben M Dunn - [email protected] * Corresponding author Published: 11 November 2003 Received: 23 July 2003 Accepted: 11 November 2003 BMC Structural Biology 2003, 3:8 This article is available from: http://www.biomedcentral.com/1472-6807/3/8 © 2003 Wlodawer et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. Abstract Background: Tripeptidyl-peptidase I, also known as CLN2, is a member of the family of sedolisins (serine-carboxyl peptidases). In humans, defects in expression of this enzyme lead to a fatal neurodegenerative disease, classical late-infantile neuronal ceroid lipofuscinosis.
    [Show full text]
  • Recombinant Bovine Enteropeptidase/Enterokinase
    Recombinant Bovine Enteropeptidase/Enterokinase Catalog Number: 4139-SE DESCRIPTION Source E. coli­derived Cys788­Lys800 (heavy chain C­terminal fragment) with an N­terminal Ala, & Ile801­His1035 (light chain) Accession # P98072 N­terminal Sequence Ala & Ile801 Analysis Structure / Form Disulfide­linked heterodimer Predicted Molecular 1.5 kDa (heavy chain C­terminal fragment), 26 kDa (light chain) Mass SPECIFICATIONS SDS­PAGE 34 kDa, reducing conditions 30 kDa, non­reducing conditions Activity Measured by its ability to cleave a colorimetric peptide substrate, N­carbobenzyloxy­Lys­ThioBenzyl ester (Z­Lys­SBzl), in the presence of 5,5’Dithio­bis (2­nitrobenzoic acid) (DTNB). Lu, D. et al. (1997) J. Biol. Chem. 272:31293. The specific activity is >35 nmol/min/µg, as measured under the described conditions. Endotoxin Level <1.0 EU per 1 μg of the protein by the LAL method. Purity >90%, by SDS­PAGE under reducing conditions and visualized by silver stain. Formulation Supplied as a 0.2 μm filtered solution in Glycerol, NaCl and HEPES. See Certificate of Analysis for details. Activity Assay Protocol Materials l Assay Buffer: 50 mM Tris, pH 7.5 l Recombinant Bovine Enteropeptidase/Enterokinase (rbEnterokinase) (Catalog # 4139­SE) l Substrate: Z­Lys­SBZL (Bachem, Catalog # M­1300), 10 mM stock in DMSO l 5,5’­dithio­bis (2­nitrobenzoic acid) (DTNB) (Sigma, Catalog # D­8130), 10 mM stock in DMSO l 96 well Clear Plate (Costar, Catalog # 92592) l Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent Assay 1. Dilute rbEnterokinase to 0.04 µg/mL in Assay Buffer. 2. Dilute Substrate to 200 µM in Assay Buffer with 200 µM of DTNB.
    [Show full text]
  • Identification of Probiotic Effector Molecules: Present State and Future
    Available online at www.sciencedirect.com ScienceDirect Identification of probiotic effector molecules: present state and future perspectives 1 2 3 Sarah Lebeer , Peter A Bron , Maria L Marco , Jan-Peter Van 4 5 5 6,7 Pijkeren , Mary O’Connell Motherway , Colin Hill , Bruno Pot , 8 9 Stefan Roos and Todd Klaenhammer Comprehension of underlying mechanisms of probiotic action Introduction will support rationale selection of probiotic strains and targeted Recently, the International Scientific Association on Pro- clinical study design with a higher likelihood of success. This biotics and Prebiotics (ISAPP) reinforced the FAO/WHO will consequently contribute to better substantiation of health definition of probiotics, with minor changes: ‘live micro- claims. Here, we aim to provide a perspective from a microbiology organisms that, when administered in adequate amounts, point of view that such comprehensive understanding is not confer a health benefit on the host’ [1]. Documentation of straightforward. We show examples of well-documented health benefits is essential, but not a trivial task, because probiotic effector molecules in Lactobacillus and Bifidobacterium the monitoring of targeted health benefits of the applied strains, including surface-located molecules such as specific pili, probiotics is difficult to establish. Moreover, a plethora of S-layer proteins, exopolysaccharides, muropeptides, as well as modes of action has been postulated behind these health more widely produced metabolites such as tryptophan-related benefits from a host perspective (Box 1). Furthermore, and histamine-related metabolites, CpG-rich DNA, and various because of the limited knowledge of the underlying enzymes such as lactase and bile salt hydrolases. We also mechanisms by which probiotics elicit their effects, repro- present recent advances in genetic tool development, ducibility and rational strain selection is challenging.
    [Show full text]
  • Structural and Mechanistic Analysis of Two Prolyl Endopeptidases: Role of Interdomain Dynamics in Catalysis and Specificity
    Structural and mechanistic analysis of two prolyl endopeptidases: Role of interdomain dynamics in catalysis and specificity Lu Shan†, Irimpan I. Mathews‡, and Chaitan Khosla†§¶ʈ Departments of †Chemical Engineering, ¶Chemistry, and §Biochemistry, Stanford University, Stanford, CA 94305; and ‡Stanford Synchrotron Radiation Laboratory, 2575 Sand Hill Road, Menlo Park, CA 94025 Edited by Christopher T. Walsh, Harvard Medical School, Boston, MA, and approved January 16, 2005 (received for review November 7, 2004) Prolyl endopeptidases (PEPs) are a unique class of serine proteases domain forms a tight barrel-shaped lid over the active site and is with considerable therapeutic potential for the treatment of celiac postulated to regulate substrate size. sprue. The crystal structures of two didomain PEPs have been Mechanisms have been proposed to account for the observed solved in alternative configurations, thereby providing insights bias of PEPs for shorter substrates. It had long been speculated that into the mode of action of these enzymes. The structure of the some conformational change might be involved in substrate binding Sphingomonas capsulata PEP, solved and refined to 1.8-Å resolu- (15). One mechanism suggested that the oscillating ␤-propeller tion, revealed an open configuration of the active site. In contrast, blades act as a ‘‘gating filter’’ during catalysis to let only short the inhibitor-bound PEP from Myxococcus xanthus was crystallized peptide substrates into the active site via the central tunnel of the (1.5-Å resolution) in a closed form. Comparative analysis of the two propeller (12, 13, 16, 17). This proposal was supported by experi- structures highlights a critical role for the domain interface in ments that connected the first and seventh blades of the propeller regulating interdomain dynamics and substrate specificity.
    [Show full text]